Literature DB >> 27535043

The Use of Urodynamics Assessment Before the Surgical Treatment of BPH.

Ahmed El-Zawahry1, Shaheen Alanee2, Angela Malan-Elzawahry2.   

Abstract

Lower urinary tract symptoms (LUTS) are a common problem in men especially with aging. The International Continence Society (ICS) revealed an overall prevalence of LUTS of about two-thirds of men age 40 years and above. The treatment approach depends on accurate determination of the underlying etiology. LUTS is not unique to benign prostate enlargement (BPE) and can be secondary to other causes. In the era where quality of care is important, accurate diagnosis and counseling to meet patients' expectations is of extreme paramount. Thus, proper assessment of patients who present with BPE and LUTS should be an important part of the work up process. Accurate diagnosis and identification of the cause will help to improve quality of treatment, optimize counseling, and improve treatment outcomes. Pressure flow urodynamic studies (PFUDs) are not only important tools that help to identify the underlying causes of LUTS; it is considered the "gold standard" for diagnosis of bladder outlet obstruction (BOO) in patients with enlarged prostate [1, 2]. However, there is a continuous debate on the value of using PFUDs and its association with improved outcomes.

Entities:  

Keywords:  Benign prostate enlargement; Benign prostatic hyperplasia; LUTS; Lower urinary tract symptoms; PFUDs

Mesh:

Year:  2016        PMID: 27535043     DOI: 10.1007/s11934-016-0626-y

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  63 in total

1.  Benign prostatic hyperplasia has precise meaning.

Authors:  P Abrams
Journal:  BMJ       Date:  2001-01-13

2.  Is the short-term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity?

Authors:  Yoshinori Tanaka; Naoya Masumori; Naoki Itoh; Seiji Furuya; Hiroshi Ogura; Taiji Tsukamoto
Journal:  Int J Urol       Date:  2006-11       Impact factor: 3.369

3.  Reproducibility of uroflow measurement: experience during a double-blind, placebo-controlled study of doxazosin in benign prostatic hyperplasia.

Authors:  M R Feneley; W D Dunsmuir; J Pearce; R S Kirby
Journal:  Urology       Date:  1996-05       Impact factor: 2.649

Review 4.  The role of invasive and non-invasive urodynamics in male voiding lower urinary tract symptoms.

Authors:  Brian A Parsons; Elizabeth Bright; Ahmed M Shaban; Anne Whitehouse; Marcus J Drake
Journal:  World J Urol       Date:  2009-11-15       Impact factor: 4.226

5.  Development of a noninvasive method to diagnose bladder outlet obstruction based on decorrelation of sequential ultrasound images.

Authors:  Muhammad Arif; Tim Idzenga; Chris L de Korte; Ron van Mastrigt
Journal:  Urology       Date:  2015-03       Impact factor: 2.649

6.  Urinary tract infection after urodynamic studies in women: incidence and natural history.

Authors:  L Bombieri; D A Dance; G W Rienhardt; A Waterfield; R M Freeman
Journal:  BJU Int       Date:  1999-03       Impact factor: 5.588

7.  Morbidity of the evaluation of the lower urinary tract with transurethral multichannel pressure-flow studies.

Authors:  H C Klingler; S Madersbacher; B Djavan; G Schatzl; M Marberger; C P Schmidbauer
Journal:  J Urol       Date:  1998-01       Impact factor: 7.450

8.  Evaluation of morbidity of multi-channel pressure-flow studies.

Authors:  D Porru; G Madeddu; G Campus; I Montisci; R M Scarpa; E Usai
Journal:  Neurourol Urodyn       Date:  1999       Impact factor: 2.696

9.  Predictives regarding outcome after transurethral resection for prostatic adenoma associated with detrusor underactivity.

Authors:  Narihito Seki; Nobuyuki Kai; Hiroshi Seguchi; Mineo Takei; Akito Yamaguchi; Seiji Naito
Journal:  Urology       Date:  2006-02       Impact factor: 2.649

10.  Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.

Authors:  Matthias Oelke; Joyce Baard; Hessel Wijkstra; Jean J de la Rosette; Udo Jonas; Klaus Höfner
Journal:  Eur Urol       Date:  2008-02-25       Impact factor: 20.096

View more
  3 in total

Review 1.  An overview of benign prostatic hyperplasia and its appreciation in Greco-Arab (Unani) system of medicine.

Authors:  Shabir Ahmad Bhat; Shameem Ahmad Rather; Naquibul Islam
Journal:  Asian J Urol       Date:  2021-05-29

Review 2.  Current consensus and controversy on the treatment of male lower urinary tract symptoms/benign prostatic hyperplasia.

Authors:  Chun-Hou Liao; Hann-Chorng Kuo
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2017 Jan-Mar

Review 3.  Precision medicine in the diagnosis and treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Authors:  Jing-Liang Chen; Yuan-Hong Jiang; Cheng-Ling Lee; Hann-Chorng Kuo
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019-08-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.